language_icon
EN
HI

Sudarshan Pharma Industries Share price

SUDARSHAN

34.1

0.02 (0.06%)
Last updated on 3 Jun, 2026 | 15:26 IST
Today's High

34.64

Today's Low

34.10

52 Week Low

18.50

52 Week High

36.95

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sudarshan Pharma Industries Chart

Sudarshan Pharma Industries Share Key Metrics

Volume
8000.00
Market Cap
820.17 CR
LTQ@LTP
4000@34.10
ATP
34.37
Var Margin
100 %
Circuit Range
32.38-35.78
Delivery %
100 %
Value
2.75 L
ASM/GSM
No
Market Lot
4000

Summary

Sudarshan Pharma Industries share price is ₹34.1 as of 4 Jun, 2026. The stock Sudarshan Pharma Industries intraday movement has stayed between ₹34.10 and ₹34.64, while on a 52-week basis,Sudarshan Pharma Industries price 52 week high is ₹36.95 & its 52 week low is ₹18.50.
In terms of trading activity, Sudarshan Pharma Industries has recorded a volume of 8000 shares, The Sudarshan Pharma Industries has a market cap of ₹240658870 CR. The stock’s Average Traded Price (ATP) stands at ₹34.37, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 4000 @ ₹34.10.
Sudarshan Pharma Industries operates within a circuit range of ₹32.38 – ₹35.78, with a Value of ₹2.75 L. The Delivery Percentage for the day is 100%. Additionally, Sudarshan Pharma Industries currently falls under the No framework, and trades with a market lot size of 4000.

Sudarshan Pharma Industries Fundamentals

View More
P/E Ratio

35.2

P/B Ratio

5.29

Div. Yield

0

Sector P/E

69.69

Sector P/B

2.97

Sec. Div. Yield

0.55

Sudarshan Pharma Industries Resistance and Support

Pivot 34.1

Resistance

First Resistance

34.95

Second Resistance

35.83

Third Resistance

36.68

Support

First Support

33.22

Second Support

32.37

Third Support

31.49

Sudarshan Pharma Industries Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

57.39%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

19.95%

Domestic Institutional Investors

0.05%

Retail

22.61%

Others

0%

Total Promoters
MAR '26
57.39%

Sudarshan Pharma Industries Corporate Actions

DateAgenda
2026-05-21Others
2026-05-15Others
2026-04-30Audited Results
2026-01-28Quarterly Results
2025-10-18Half Yearly Results
2025-08-14Quarterly Results
2025-06-19Others
2025-04-24Audited Results
2025-01-10To consider issue of Warrants

Sudarshan Pharma Industries News

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Sudarshan Pharma Industries published a postal ballot notice for shareholder approval. Key resolutions include migrating from BSE SME to the Main Board, listing on NSE, and appointing two new directors. This move aims to enhance market visibility and corporate governance.
May 26 2026 10:32:00

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Sudarshan Pharma conducts postal ballot for a strategic move to migrate equity shares from the BSE SME Platform to BSE Main Board and NSE Main Board. This aims to boost market recognition and investor participation. Shareholders will also vote on two director appointments.
May 25 2026 14:40:23

Sudarshan Pharma Industries Ltd - 543828 - Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities.

Sudarshan Pharma Industries has revised the conversion rate for its Foreign Currency Convertible Bond (FCCB) issue. The new fixed exchange rate for the USD 20 million FCCB will be Rs.96.8441 per US Dollar, updated from the earlier Rs.95.93 per US Dollar.
May 21 2026 12:48:11

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment

Sudarshan Pharma Industries allotted US$10 million in 8% Foreign Currency Convertible Bonds (FCCBs) due 2029. These bonds are convertible into equity shares at Rs.30.19 each. The company also holds an option for an additional US$10 million allotment.
May 21 2026 12:35:57

Sudarshan Pharma Industries Ltd - 543828 - Update on board meeting

Sudarshan Pharma's board meeting, originally scheduled for May 22, 2026, has been pre-poned to May 21, 2026. The agenda includes considering the migration of the company's equity shares from the SME Platform to the Main Boards of BSE and NSE, subject to shareholder approval.
May 18 2026 21:02:17

Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday, 22Nd May, 2026

Sudarshan Pharma's Board will convene on May 22, 2026, to discuss and approve the migration of its equity shares from the SME Platform to the Main Board of BSE and for listing on the Main National Stock Exchange (NSE). This move aims to enhance market visibility and liquidity.
May 18 2026 18:10:37

Sudarshan Pharma Industries Ltd - 543828 - Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Announcement Dated 15/05/2026

Sudarshan Pharma Industries board has approved the issuance of up to USD 20 million in 8.00% Senior Unsecured Foreign Currency Convertible Bonds (FCCBs) due 2029. This international offering will open on May 18, 2026, and could potentially result in the issuance of approximately 6.35 crore equity shares upon conversion.
May 18 2026 13:19:17
Read More

Sudarshan Pharma Industries Management

NamePosition
Nirav ShahCompany Secretary & Compliance Officer
Hemal Vasantrai MehtaChairman & Managing Director
View More

Sudarshan Pharma Industries FAQs

The Buying Price of Sudarshan Pharma Industries share is 34.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sudarshan Pharma Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sudarshan Pharma Industries, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sudarshan Pharma Industries shares is 35.2. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sudarshan Pharma Industries shares is 5.29. Useful to assess the stock's value relative to its book value.

To assess Sudarshan Pharma Industries’s valuation compare Sector P/E, P/B which are 69.69 & 2.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sudarshan Pharma Industries is 820.17 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sudarshan Pharma Industries share price is 36.95 & 18.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sudarshan Pharma Industries belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost